1. Home
  2. GTLS vs BIO Comparison

GTLS vs BIO Comparison

Compare GTLS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chart Industries Inc.

GTLS

Chart Industries Inc.

HOLD

Current Price

$209.79

Market Cap

10.0B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$296.48

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTLS
BIO
Founded
1859
1952
Country
United States
United States
Employees
11777
7450
Industry
Metal Fabrications
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
8.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GTLS
BIO
Price
$209.79
$296.48
Analyst Decision
Hold
Buy
Analyst Count
8
4
Target Price
$205.67
$339.75
AVG Volume (30 Days)
1.0M
287.8K
Earning Date
05-01-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.31
$2.74
Revenue Next Year
$5.89
$3.20
P/E Ratio
$240.25
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$163.23
$236.73
52 Week High
$209.79
$343.12

Technical Indicators

Market Signals
Indicator
GTLS
BIO
Relative Strength Index (RSI) 67.51 54.01
Support Level $206.59 $293.88
Resistance Level N/A $312.51
Average True Range (ATR) 0.38 10.19
MACD 0.12 0.09
Stochastic Oscillator 90.14 75.57

Price Performance

Historical Comparison
GTLS
BIO

About GTLS Chart Industries Inc.

Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: